Latest Breaking News On - Amgen launches amjevita x2014 first biosimilar to humira in the united states - Page 1 : comparemela.com

Amgen announced today the launch of AMJEVITA (adalimumab-atto), a biosimilar to AbbVie's HUMIRA (adalimumab), in the United States. AMJEVITA was the first HUMIRA biosimilar approved.

United-states
Amgen
European-union
Wholesale-acquisition-cost
Mondaq
Amgen-launches-amjevita-x2014-first-biosimilar-to-humira-in-the-united-states
Food
Drugs
Healthcare
Life-sciences
Life-sciences